IQVIA Holdings had its Relative Strength (RS) Rating upgraded from 69 to 72 Tuesday — a welcome improvement, but still shy of the 80 or higher score you prefer to see.
How To Invest In Stocks In Both Bull And Bear Markets
This exclusive rating from Investor's Business Daily identifies share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the best stocks tend to have an 80 or better RS Rating in the early stages of their moves. See if IQVIA Holdings can continue to rebound and hit that benchmark.
While it's not currently an ideal time to jump in, see if the stock is able to establish and enter a buy zone in heavy volume.
IQVIA Holdings showed 6% EPS growth in its most recent report. Revenue gains came in at 5%.
IQVIA Holdings holds the No. 2 rank among its peers in the Medical-Research Equipment/Services industry group. Medpace Holdings is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
